Log in to your account:
Biogen (BIIB) PT Lowered to $290 at Oppenheimer
March 21, 2019 12:42 PM
Oppenheimer analyst Jay Olson lowered the price target on Biogen (NASDAQ: BIIB) to $290.00 (from $375.00) while maintaining a Outperform ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Analyst PT Change
Biogen (BIIB) PT Lowered to $300 at H.C. Wainwright
March 25, 2019 7:49 AM